Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Nu open voor aanvraagWaar het om gaat
Dit onderwerp richt zich op gezondheidseconomisch onderzoek voor kankerpatiënten, zonder specifieke bedrijfsgrootte of fasebeperkingen.
Samenvatting
Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Vergelijkbare regelingen
Dichtstbij qua inhoud — ook over de taalgrens (RVO ↔ EU-calls), via embeddings.
- Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers · EU · 93% · open
- Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers · EU · 92% · open
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines · EU · 92% · open
- Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes · EU · 91% · open
- European Partnership for Pandemic Preparedness (Phase 2) · EU · 91% · open
- Earlier and more precise palliative care · EU · 91% · open